Finance

Beta
Lists
KYMR:NASDAQ
Kymera Therapeutics Inc
USD 119,35
+0,29%
(+0,35) 1D
USD 117,90
-1,21% (-1,45)
After hours
Closed: 10 Jul., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KYMR...
Open
USD 119,52
High
USD 120,60
Low
USD 114,00
Mkt. cap
9,82 mjd
Avg. vol.
1,08 m
Volume
665,91 k
52-wk high
USD 130,05
52-wk low
USD 36,65
EPS
-USD 3,57
Beta
1,95
Shares outstanding
82,26 m
No. of employees
253
Open
USD 119,52
High
USD 120,60
Low
USD 114,00
Mkt. cap
9,82 mjd
Avg. vol.
1,08 m
Volume
665,91 k
52-wk high
USD 130,05
52-wk low
USD 36,65
EPS
-USD 3,57
Beta
1,95
Shares outstanding
82,26 m
No. of employees
253
News stories
From sources across the web
About Kymera Therapeutics Inc
CEO-
Employees253
Founded2015
HeadquartersWatertown, Massachusetts, Verenigde State van Amerika
Sector-
Websitekymeratx.com
Analyst ratings
Based on 14 analysts giving stock ratings to KYMR in the past 3 months
Strong buy
Buy
14
Hold
0
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for KYMR in the last 3 months.
Highest
Current USD 119,35
USD 155,00 (+29,87%)
Average
USD 127,67 (+6,97%)
Lowest
USD 106,00 (-11,19%)
Analyst
Recommendation
Action
Price target
Projected
Date
Daniel Giraldo
Bank of America Securities
Buy
Reiterated
USD 125,00
+4,7%
06/29/2026
Tazeen Ahmad
Bank of America Securities
Buy
Reiterated
USD 125,00
+4,7%
06/30/2026
Srikripa Devarakonda
Truist Financial
Buy
Reiterated
USD 136,00
+14%
06/29/2026
Mayank Mamtani
B. Riley Securities
Buy
Reiterated
USD 155,00
+29,9%
06/29/2026
Unknown Analyst
B. Riley Securities
Buy
Maintained
USD 155,00
+29,9%
06/26/2026
Edward Nash
Canaccord Genuity
Buy
Reiterated
USD 129,00
+8,1%
06/26/2026
Unknown Analyst
Wells Fargo
Buy
Reiterated
USD 116,00
-2,8%
06/26/2026
Judah Frommer
Morgan Stanley
Buy
Maintained
USD 119,00
-0,3%
06/25/2026
Geoff Meacham
Citi
Buy
Maintained
USD 120,00
+0,5%
06/25/2026
Jeet Mukherjee
BTIG
Buy
Maintained
USD 134,00
+12,3%
06/25/2026
Brian Cheng
J.P. Morgan
Buy
Maintained
-
-
06/25/2026
Eliana Merle
Barclays
Buy
Maintained
USD 133,00
+11,4%
06/22/2026
Marc Frahm
TD Cowen
Buy
Maintained
-
-
05/05/2026
Andrew Fein
H.C. Wainwright
Buy
Maintained
USD 134,00
+12,3%
05/04/2026
Bradley Canino
Guggenheim
Buy
Reiterated
USD 125,00
+4,7%
04/30/2026
Brian Abrahams
RBC Capital
Buy
Maintained
USD 106,00
-11,2%
04/30/2026
Kelly Shi
Jefferies
Buy
Initiated
USD 110,00
-7,8%
03/15/2026
Faisal Khurshid
Jefferies
Buy
Initiated
USD 110,00
-7,8%
03/15/2026
David Dai
UBS
Buy
Maintained
USD 128,00
+7,2%
03/03/2026
Sudan Loganathan
Stephens
Buy
Maintained
USD 100,00
-16,2%
03/02/2026
Derek Archila
Wells Fargo
Buy
Maintained
USD 116,00
-2,8%
03/02/2026
Jeff Jones
Oppenheimer
Buy
Reiterated
USD 120,00
+0,5%
02/27/2026
Biren Amin
Piper Sandler
Buy
Maintained
USD 140,00
+17,3%
02/26/2026
Joseph Catanzaro
Mizuho Securities
Buy
Reiterated
-
-
01/29/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
11,48 m
2,76 m
2,87 m
34,36 m
Cost of goods sold
78,39 m
74,09 m
83,83 m
98,16 m
Cost of revenue
78,39 m
74,09 m
83,83 m
98,16 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17,64 m
17,34 m
16,94 m
20,36 m
Operating expense
17,64 m
17,34 m
16,94 m
20,36 m
Total operating expenses
96,03 m
91,43 m
100,77 m
118,52 m
Operating income
-84,56 m
-88,67 m
-97,90 m
-84,15 m
Other non operating income
-
-
-
5,00 k
EBT including unusual items
-76,61 m
-82,18 m
-86,98 m
-69,23 m
EBT excluding unusual items
-76,61 m
-78,32 m
-86,98 m
-69,23 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-76,61 m
-82,18 m
-86,98 m
-69,23 m
Net profit margin
-667,60%
-2 973,05%
-3 030,70%
-201,47%
Earnings per share
-0,95
-0,94
-0,98
-0,71
Interest and investment income
8,05 m
10,44 m
11,00 m
14,98 m
Interest expense
-108,00 k
-98,00 k
-90,00 k
-66,00 k
Net interest expenses
7,94 m
10,35 m
10,92 m
14,92 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-83,17 m
-85,82 m
-97,46 m
-82,13 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer